19Jun
Healthcare & Life Sciences Private Equity Deal Tracker: H.I.G BioHealth Sells Vertiflex to Boston Scientific
H.I.G. BioHealth Partners, the life-science investment affiliate of H.I.G. Capital, has announced the sale of Vertiflex to Boston Scientific. The total equity value of the sale is approximately $465 million in cash, with additional payments...
By:
McGuireWoods LLP
Related
Recently proposed IRS regulations reverse the reasoning of several past IRS private letter rulings r...
Read More >
A recap of some of the most well-read M&A publications on JD Supra during 2019....By: Beacon Insight...
Read More >
Valid arbitration agreements may prevent class notices from being sent to employees that would other...
Read More >
The COVID-19 pandemic is one of the biggest threats to the global economy and financial markets that...
Read More >
The Williams Cos., Inc. v. Energy Transfer LP, C.A. No. 12168-VCG (Del. Ch. July 2, 2020) - The Cou...
Read More >
The decision leaves the door open for buyers to argue that inflexible ordinary course covenants can ...
Read More >